Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 58Unknown 11Recruiting 6Terminated 5Withdrawn 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 40Genitourinary 14Head & Neck 12Breast 5Thoracic 4Gynecologic 4Lymphoid 3Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Dermatologic 1CNS 1

Conditions

Advanced Solid Tumor 1

Interventions

Injections 9Interviews as Topic 4Cisplatin 4Carboplatin 4toripalimab 3fludarabine 3envafolimab 3Pemetrexed 3Iodine-125 3Immune Checkpoint Inhibitors 3Fluorodeoxyglucose F18 3tislelizumab 2pembrolizumab 2Paclitaxel 2Oxaliplatin 2Drug Therapy 2Cyclophosphamide 2Cryosurgery 2Capecitabine 2Blood Specimen Collection 2trastuzumab deruxtecan 1spartalizumab 1somatostatin receptor 2 1regorafenib 1olaparib 1nabiximols 1malic acid 1lenvatinib 1ivarmacitinib 1irinotecan sucrosofate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Gemcitabine × Other solid neoplasm × Clear all
NCT06446388 2024-06-06

Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors

Qilu Pharmaceutical Co., Ltd.

Phase 2 Not yet recruiting
360 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡